Evidence map›Paper›PMID 32290794›Full record

ReviewRedox report : communications in free radical research2020

Mitochondrial complex II and reactive oxygen species in disease and therapy.

Katerina Hadrava Vanova, Michal Kraus, Jiri Neuzil, Jakub Rohlena

Open access · goldAbstract readReview
In one paragraph

Review in Redox report : communications in free radical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 149 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Katerina Hadrava VanovaInstitute of Biotechnology of the Czech Academy of Sciences, Prague-West, Czech Republic.
Michal KrausInstitute of Biotechnology of the Czech Academy of Sciences, Prague-West, Czech Republic.
Jiri NeuzilInstitute of Biotechnology of the Czech Academy of Sciences, Prague-West, Czech Republic.
Jakub RohlenaInstitute of Biotechnology of the Czech Academy of Sciences, Prague-West, Czech Republic.
Czech Academy of Sciences, Institute of Biotechnology · CZGriffith University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increasing evidence points to the respiratory Complex II (CII) as a source and modulator of reactive oxygen species (ROS). Both functional loss of CII as well as its pharmacological inhibition can lead to ROS generation in cells, with a relevant impact on the development of pathophysiological conditions, i.e. cancer and neurodegenerative diseases. While the basic framework of CII involvement in ROS production has been defined, the fine details still await clarification. It is important to resolve these aspects to fully understand the role of CII in pathology and to explore its therapeutic potential in cancer and other diseases.

Indexed as

Molecular Targeted TherapyAnimalsElectron TransportElectron Transport Complex IIHumansMitochondriaMitochondrial DiseasesReactive Oxygen SpeciesElectron Transport Complex IIReactive Oxygen SpeciescancermitochondriaOXPHOSreactive oxygen speciesRespiratory complex IIsuccinatesuccinate dehydrogenasetricarboxylic acid cycle

Identifiers

PMID32290794
PMCPMC7178880
OpenAlexW3016117371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.